Video interview with Dyson featured on IdeasProject.com, Nokia's new website, which provides innovative ways to interact with thought leaders and their "big ideas" about the future of communications
San Francisco, CA (PRWEB) February 12, 2009 -- Esther Dyson, IT investor, catalyst to numerous start-ups, and director of genetic testing service 23andme, says that as we further our understanding of genetics, scientists in turn will be enabled to reconfigure how genes work to achieve desired results. Dyson foresees future technology where scientists will be able to inject a specific genomic structure into an individual to save their life, or through proper genomic identification, identify the appropriate drug to treat their ailment.
A video interview with Dyson talking about genetic information being disruptive is featured on IdeasProject, a unique website developed by Nokia. IdeasProject is an online space that provides a new way to interact with thought leaders and their big ideas about the future of connected communications. For more on Dyson's idea, visit http://www.ideasproject.com/idea_person.webui?id=1111
"The more people know, the more conscious they are of how things work, and the more likely they are to make better decisions," said Dyson. "One area in which people's decisions have a huge impact is their own personal health and understanding of how that works. The impact of their behavior is going to make more people make better decisions of their own volition without being forced or deluded into doing things they don't want to do."
"We are proud to feature such luminaries as Esther Dyson in the IdeasProject," says Valerie Buckingham, director of technology marketing, Nokia. "In the same way that Esther h
Copyright©2009 Vocus, Inc.
All rights reserved